Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation

DMM Disease Models and Mechanisms

Volumn 3, Issue 3-4, 2010, Pages 224-235

  Ortega, Nathalie ^a,d   Wang, Ke ^a,b,e   Ferrara, Napoleone ^c   Werb, Zena ^a   Vu, Thiennu H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

^d INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^e THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; BONE DYSPLASIA; ENCHONDRAL OSSIFICATION; GROWTH PLATE; MOUSE; NONHUMAN; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION;

ACID PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; CARTILAGE; CHONDROCYTES; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; GROWTH PLATE; HUMANS; HYPERTROPHY; ISOENZYMES; MATRIX METALLOPROTEINASE 9; MICE; MODELS, BIOLOGICAL; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; PROTEASE INHIBITORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 77949477747     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.004226     Document Type: Article

References (52)

1. Aldridge, S. E., Lennard, T. W., Williams, J. R. and Birch, M. A. (2005). Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 335, 793-798.
2. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R. and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23, 354-358.
3. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z. et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
4. Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C., Mitchell, P., Hambor, J., Diekmann, O., Tschesche, H. et al. (1997). Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest 99, 1534-1545.
5. Bischof, P., Truong, K. and Campana, A. (2003). Regulation of trophoblastic gelatinases by proto-oncogenes. Placenta 24, 155-163.
6. Cohen, M. M., Jr (2000a). Merging the old skeletal biology with the new. I. Intramembranous ossification, endochondral ossification, ectopic bone, secondary cartilage, and pathologic considerations. J. Craniofac. Genet. Dev. Biol. 20, 84-93.
7. Cohen, M. M., Jr (2000b). Merging the old skeletal biology with the new. II. Molecular aspects of bone formation and bone growth. J. Craniofac. Genet. Dev. Biol. 20, 94-106.
8. Cohen, M. M., Jr (2006). The new bone biology: pathologic, molecular, and clinical correlates. Am. J. Med. Genet. A 140, 2646-2706.
9. Colnot, C. (2005). Cellular and molecular interactions regulating skeletogenesis. J. Cell Biochem. 95, 688-697.
10. Daci, E., Everts, V., Torrekens, S., Van Herck, E., Tigchelaar-Gutterr, W., Bouillon, R. and Carmeliet, G. (2003). Increased bone formation in mice lacking plasminogen activators. J. Bone Miner. Res. 18, 1167-1176.
11. Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R. et al. (1999). RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424.
12. Du, R., Petritsch, C., Lu, K., Liu, P., Haller, A., Ganss, R., Song, H., Vandenberg, S. and Bergers, G. (2008). Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 10, 254-264.
13. Egeblad, M., Shen, H. C., Behonick, D. J., Wilmes, L., Eichten, A., Korets, L. V., Kheradmand, F., Werb, Z. and Coussens, L. M. (2007). Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Dev. Dyn. 236, 1683-1693.
14. Engsig, M. T., Chen, Q. J., Vu, T. H., Pedersen, A. C., Therkidsen, B., Lund, L. R., Henriksen, K., Lenhard, T., Foged, N. T., Werb, Z. et al. (2000). Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151, 879-890.
15. Erlebacher, A., Filvaroff, E. H., Ye, J. Q. and Derynck, R. (1998). Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell 9, 1903-1918.
16. Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z. and Ferrara, N. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623-628.
17. Grigoriadis, A. E., Wang, Z. Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A. and Wagner, E. F. (1994). c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448.
18. Gustafsson, E., Aszodi, A., Ortega, N., Hunziker, E. B., Denker, H. W., Werb, Z. and Fassler, R. (2003). Role of collagen type II and perlecan in skeletal development. Ann. N. Y. Acad. Sci. 995, 140-150.
19. Hackel, C., Radig, K., Rose, I. and Roessner, A. (1995). The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study. Anat. Embryol. (Berl.) 192, 363-368.
20. Haigh, J. J., Gerber, H. P., Ferrara, N. and Wagner, E. F. (2000). Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 127, 1445-1453.
21. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D. and Moore, M. A. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637.
22. Hiltunen, M. O., Ruuskanen, M., Huuskonen, J., Mahonen, A. J., Ahonen, M., Rutanen, J., Kosma, V. M., Mahonen, A., Kroger, H. and Yla-Herttuala, S. (2003). Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J. 17, 1147-1149.
23. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I. et al. (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92.
24. Holmbeck, K., Bianco, P., Chrysovergis, K., Yamada, S. and Birkedal-Hansen, H. (2003). MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J. Cell Biol. 163, 661-671.
25. Inada, M., Wang, Y., Byrne, M. H., Rahman, M. U., Miyaura, C., Lopez-Otin, C. and Krane, S. M. (2004). Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA 101, 17192-17197.
26. Inoue, K., Mikuni-Takagaki, Y., Oikawa, K., Itoh, T., Inada, M., Noguchi, T., Park, J. S., Onodera, T., Krane, S. M., Noda, M. et al. (2006). A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J. Biol. Chem. 281, 33814-33824.
27. Karsenty, G. and Wagner, E. F. (2002). Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406.
28. Li, J., Sarosi, I., Yan, X. Q., Morony, S., Capparelli, C., Tan, H. L., McCabe, S., Elliott, R., Scully, S., Van, G. et al. (2000). RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97, 1566-1571.
29. Li, S. W., Prockop, D. J., Helminen, H., Fassler, R., Lapvetelainen, T., Kiraly, K., Peltarri, A., Arokoski, J., Lui, H., Arita, M. et al. (1995). Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev. 9, 2821-2830.
30. Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R. and Carmeliet, G. (2002). Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111, 61-73.
31. Maes, C., Stockmans, I., Moermans, K., Van Looveren, R., Smets, N., Carmeliet, P., Bouillon, R. and Carmeliet, G. (2004). Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113, 188-199.
32. Marks, S. C., Jr and Lane, P. W. (1976). Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67, 11-18.
33. Martignetti, J. A., Aqeel, A. A., Sewairi, W. A., Boumah, C. E., Kambouris, M., Mayouf, S. A., Sheth, K. V., Eid, W. A., Dowling, O., Harris, J. et al. (2001). Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 28, 261-265.
34. McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J. et al. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658.
35. Midy, V. and Plouet, J. (1994). Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199, 380-386.
36. Mosig, R. A., Dowling, O., DiFeo, A., Ramirez, M. C., Parker, I. C., Abe, E., Diouri, J., Aqeel, A. A., Wylie, J. D., Oblander, S. A. et al. (2007). Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum. Mol. Genet. 16, 1113-1123.
37. Niida, S., Kondo, T., Hiratsuka, S., Hayashi, S., Amizuka, N., Noda, T., Ikeda, K. and Shibuya, M. (2005). VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proc. Natl. Acad. Sci. USA 102, 14016-14021.
38. Olsen, B. R., Reginato, A. M. and Wang, W. (2000). Bone development. Annu. Rev. Cell Dev. Biol. 16, 191-220.
39. Ortega, N., Behonick, D. J. and Werb, Z. (2004). Matrix remodeling during endochondral ossification. Trends Cell Biol. 14, 86-93.
40. Ortega, N., Behonick, D. J., Colnot, C., Cooper, D. N. and Werb, Z. (2005). Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol. Biol. Cell 16, 3028-3039.
41. Provot, S. and Schipani, E. (2005). Molecular mechanisms of endochondral bone development. Biochem. Biophys. Res. Commun. 328, 658-665.
42. Schipani, E., Ryan, H. E., Didrickson, S., Kobayashi, T., Knight, M. and Johnson, R. S. (2001). Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15, 2865-2876.
43. Stickens, D., Behonick, D. J., Ortega, N., Heyer, B., Hartenstein, B., Yu, Y., Fosang, A. J., Schorpp-Kistner, M., Angel, P. and Werb, Z. (2004). Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131, 5883-5895.
44. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F. V., Jr, Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J. L., Daugherty, A. et al. (2002). Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. USA 99, 9656-9661.
45. Tondravi, M. M., McKercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M., Maki, R. and Teitelbaum, S. L. (1997). Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81-84.
46. Tuysuz, B., Mosig, R., Altun, G., Sancak, S., Glucksman, M. J. and Martignetti, J. A. (2009). A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects. Eur. J. Hum. Genet. 17, 565-572.
47. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
48. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T. and Shultz, L. D. (1990). The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442-444.
49. Zelzer, E. and Olsen, B. R. (2005). Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr. Top Dev. Biol. 65, 169-187.
50. Zelzer, E., McLean, W., Ng, Y. S., Fukai, N., Reginato, A. M., Lovejoy, S., D'Amore, P. A. and Olsen, B. R. (2002). Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893-1904.
51. Zelzer, E., Mamluk, R., Ferrara, N., Johnson, R. S., Schipani, E. and Olsen, B. R. (2004). VEGFA is necessary for chondrocyte survival during bone development. Development 131, 2161-2171.
52. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y. and Tryggvason, K. (2000). Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA 97, 4052-4057.